Author:
Shih Tsung-Chieh,Wang Lijun,Wang Hsiao-Chi,Wan Yu-Jui Yvonne
Funder
USA National Institutes of Health
UC Davis
Comprehensive Cancer Center
Subject
Gastroenterology,Hepatology
Reference59 articles.
1. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019
2. Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib;Ronot;Oncologist,2014
3. Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients;Li;Afr Health Sci,2013
4. Glypican-3: a new target for diagnosis and treatment of hepatocellular carcinoma;Guo;J Cancer,2020
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献